The New Rules of Drug Pricing, Access, and Value

April 29, 2021 11:00 AM - 12:00 PM

Webinar, click "live-stream" button to view

Add to Calendar 4/29/2021 11:00:00 AM 4/29/2021 12:00:00 PM The New Rules of Drug Pricing, Access, and Value

While the biopharma industry’s response to COVID-19 – creating and launching multiple breakthrough innovations in record time – has generated enormous confidence and respect for biopharma, it has also reinvigorated the drug pricing debate. Now, more than ever, it’s essential for companies to have a strategic and robust approach to pricing.

In this virtual Forum, Laurie Halloran (President & CEO of Halloran Consulting Group), Laura Randa (Chief Executive Officer, Randa BioPharma Solutions), Jennifer Petrillo Billet (Director, Sage Therapeutics) and Alex Santini (Senior Vice President of Market Access, Nektar Therapeutics)  will share their guidance and expertise on developing and implementing drug pricing, value, and access strategies. Topics will include: 

  • The importance of planning, with a focus on late-stage clinical trials
  • Best practices for working with payors
  • Market access and reimbursement – at home and abroad


Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only.


NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Webinar, click "live-stream" button to view
Chief Executive Officer, Randa BioPharma Solutions
Laura E. Randa serves as Chief Executive Officer for Randa BioPharma Solutions, a boutique consulting firm focused on building start-up life sciences companies, advancing pipeline and in-line assets by providing transformative solutions for the life sciences industry. Ms. Randa serves as a Strategic Advisor and Member of the Advisory Board of Tutela Pharmaceuticals, a nonprofit company targeting continued access and affordability of single-source marketed pharmaceuticals. She also is a Strategic Advisor and Member of the Advisory Board of Emedgene which is operating the world’s first completely automated genetic interpretation platform. She is a founding member of the American Association of People with Disabilities’ new Disability Advisory Roundtable. She serves as Co-Chair of the Executive Women in Business Capital Region, Women’s Health Executive Committee and Life Science Council Board member at Springboard Enterprises and serves as a strategic advisor to the CEO and Founder Hello Career Guru.